Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00451841 · ClinicalTrials.gov registry record
Exhaled Breath Condensate pH in Patients With Cough Caused by Gastroesophageal Reflux
A clinical trial, sponsored by University of Massachusetts, Worcester.
- Terminated
- Registry status
- 30
- Enrollment target
NCT00451841 is a clinical trial that was terminated before completion, run by University of Massachusetts, Worcester. The registered enrollment target is 30 participants.
The verdict
NCT00451841 was terminated before completion, sponsored by University of Massachusetts, Worcester.
- TERMINATED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Cough is the most common complaint for which patients seek medical attention in the United States, accounting for approximately 1 billion dollars in health care expenses annually. Gastroesophageal reflux disease (GERD) is the sole cause of chronic cough in up to 20-40% of all cases. The majority of these patients with GERD-induced cough have no classic "heartburn" symptoms, so this important cause of cough can thus be difficult to detect. Our hypothesis is that changes in exhaled breath condensate (EBC) pH can be used as a sensitive and non-invasive marker to identify subjects with cough caused by acid reflux.
Interventions
- DEVICE RTube Exhaled Breath Condensate Collection System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2007-03 |
| Est. Completion | 2013-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00451841
The ClinicalTrials.gov registry entry for NCT00451841 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RTube Exhaled Breath Condensate Collection System is the first listed.
NCT00451841 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00451841 about?
NCT00451841 is a clinical study titled "Exhaled Breath Condensate pH in Patients With Cough Caused by Gastroesophageal Reflux". Cough is the most common complaint for which patients seek medical attention in the United States, accounting for approximately 1 billion dollars in health care expenses annually. Gastroesophageal reflux disease (GERD) is the sole cause of chronic cough in up to 20-40% of all cases. The majority of ...
What is the current status of trial NCT00451841?
This trial is currently terminated. The enrollment target is 30 participants. The study started on 2007-03. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00451841?
The interventions under investigation include: RTube Exhaled Breath Condensate Collection System (DEVICE).
Who is sponsoring clinical trial NCT00451841?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.